Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation

Blood

Volumn 91, Issue 9, 1998, Pages 3518-3523

  Zent, C S ^a   Wilson, C S ^a   Tricot, G ^a   Jagannath, S ^a   Siegel, D ^a   Desikan, K R ^a   Munshi, N ^a   Bracy, D ^a   Barlogie, B ^a,b   Butch, A W ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ALPHA2B INTERFERON; CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GLUCOCORTICOID; IMMUNOGLOBULIN; MELPHALAN; MONOCLONAL ANTIBODY;

ARTICLE; BONE MARROW CELL; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; STEM CELL TRANSPLANTATION;

EID: 0032079443     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.9.3518     Document Type: Article

References (13)

1. Foerster J: Multiple myeloma, in Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (eds): Wintrobe's Clinical Hematology (ed 9). Philadelphia, PA, Lea & Febiger, 1993, p 2219
2. Kyle RA, Robinson RA, Katzmann JA: The clinical aspects of biclonal gammopathies. A review of 57 cases. Am J Med 71:999, 1981
3. Vesole D, Vanier A, Flick J, Jagannath S, Glenn L. Pappas A, Barlogie B: Monoclonal immunoglobulin isotype switches in multiple myeloma patients following high-dose chemotherapy. Blood 80:122a, 1992(abstr)
4. Mitus AJ, Stein R, Rappeport JM, Antin JH, Weinstein HJ, Alper CA, Smith BR: Monoclonal and oligoclonal gammopathy after bone marrow transplantation. Blood 74:2764, 1989
5. Gerritsen EJA, Van Tol MJD, Lankester AC, van der Weijden-Ragas CPM, Jol-van der Zijde CM, Ouderman-Gruber NJ, Radl J, Vossen JM: Immunoglobulin levels and monoclonal gammopathies in children after bone marrow transplantation. Blood 82:3493, 1993
6. Gerritsen EJA, Van Tol MJD, Van't Veer MB, Wels JMA, Khouw IMSL, Touw CR, Jol-van der Zijde CM, Hermans J, Rumke HC, Radl J, Vossen JM: Clonal dysregulation of the antibody response to tetanustoxoid after bone marrow transplantation. Blood 84:4374, 1994
7. Durie GGM. Salmon SE: A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36:842, 1975
8. Vesole DH, Tricot G, Jagannath S, Desikan KR, Siegel D, Bracy D, Miller L, Cheson B, Crowley J, Barlogie B: Autotransplants in multiple myeloma: What have we learned? Blood 88:838, 1996
9. Barlogie B, Alexanian R, Pershouse M, Smallwood L, Smith L: Cytoplasmic immunoglobulin content in multiple myeloma. J Clin Invest 76:765, 1985
10. Barlogie B, Jagannath S, Vesole DH, Nauke S, Cheson B, Mattox S, Bracy D, Salmon S, Jacobson J, Crowley J, Tricot G: Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood 89:789, 1997
11. Van den Berg P, Radl J, Lowenberg B, Swart ACW: Homogeneous antibodies in lethally irradiated and autologous bone marrow reconstituted Rhesus monkeys. Clin Exp Immunol 23:355, 1976
12. Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flomenberg N: B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: A recapitulation of normal B-cell ontogeny. Blood 76:1647, 1990
13. Kyle RA, Lust JA: Monoclonal gammopathies of undetermined significance. Semin Hematol 26:176, 1989